Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32532935!ä!32532935 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infez+Med 2020 ; 28 (suppl 1): 29-36 Nephropedia Template TP {{tp|p=32532935|t=2020. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia |pdf=|usr=}}{{32532935}} gab.com Text Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia JO: Infez Med http://www.kidney.de/pget.php?&tw=1&pmid=32532935 #FOAvip We reviewed studies reporting bacterial and fungal co-infections in patients with COVID-19. The majority were retrospective studies with poor quality data biased with short follow-up and selection of patients. Septic shock was reported in 4% to 33.1% of patients. Seventy-one to 100% of patients received antibacterial treatments. Invasive pulmonary aspergillosis seems to be an increasingly observed complication in critically ill patients with SARS-CoV-2 infection as previously reported in patients hospitalized in ICU with severe influenza. High quality prospective studies are urgently needed to verify the incidence of bacterial and fungal infections and their role on the outcome of COVID-19. Twit Text FOAVip Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia ????Infez Med http://www.kidney.de/pget.php?&tw=1&pmid=32532935 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32532935 #FOAvip English Wikipedia <ref>{{Cite pmid|32532935}}</ref> Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia #MMPMID32532935 Antinori S; Galimberti L; Milazzo L; Ridolfo AL Infez Med 2020[Jun]; 28 (suppl 1): 29-36 PMID32532935show ga We reviewed studies reporting bacterial and fungal co-infections in patients with COVID-19. The majority were retrospective studies with poor quality data biased with short follow-up and selection of patients. Septic shock was reported in 4% to 33.1% of patients. Seventy-one to 100% of patients received antibacterial treatments. Invasive pulmonary aspergillosis seems to be an increasingly observed complication in critically ill patients with SARS-CoV-2 infection as previously reported in patients hospitalized in ICU with severe influenza. High quality prospective studies are urgently needed to verify the incidence of bacterial and fungal infections and their role on the outcome of COVID-19. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Bacterial Infections/*epidemiology[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques[MESH] |Comorbidity[MESH] |Coronavirus Infections/diagnosis/*epidemiology[MESH] |Cross Infection/epidemiology[MESH] |Female[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Invasive Pulmonary Aspergillosis/epidemiology[MESH] |Male[MESH] |Middle Aged[MESH] |Mycoses/*epidemiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*epidemiology[MESH] |Retrospective Studies[MESH]Bacterial and fungal infections among patients with SARS-CoV-2 pneumon(epmc).pdf DeepDyve Pubget Overpricing